FEMTO TECHNOLOGIES INC.

Vancouver, BC – May 15, 2025 – TheNewswire – Femto Technologies Inc. (Nasdaq: FMTO ) (“ Femto ” or the “ Company ”), a pioneering femtech company has released its financial results for three-month ended March 31, 2025. Full versions of Femto's unaudited consolidated interim financial statements and management discussion and analysis for the period, can be found on www.sedarplus.ca .   Q1 2025 Financial and Business Highlights:» Mehr auf thenewswire.com

Vancouver, BC – May 15, 2025 – TheNewswire - Femto Technologies Inc. (Nasdaq: FMTO) (the “ Company ” or “ Femto ”), a pioneering femtech company, announce s that its Board of Directors has authorized a stock repurchase program (the “ Stock Repurchase Program ”) to repurchase up to 43,025 subordinate voting shares of the Company (the “ Subordinate Voting Shares ”), representing up to 5% of the issued and outstanding Subordinate Voting Shares as at the close of business on May 14, 2025.  The Stock Repurchase Program will commence on May 20, 2025, and is expected to last for up to six months.  The Stock Repurchase Program does not obligate the Company to repurchase any dollar amount or number of shares, and the program may be extended, modified, suspended or discontinued at any time.   “Our stock repurchase authorization reflects the Board's decision to support the company's capital and increase shareholder value and return,” said Yftah Ben Yaackov, Chief Executive Officer. “We are confident in our ability to generate increasing amounts of free cash flow and are committed to continue to strategically deploy capital where we believe it can generate stockholder value.”» Mehr auf thenewswire.com

Nasdaq-Listed Femtech Innovator, creator of Sensera, Advances AI-Driven Feminine Wellness Solutions   Los Angeles, California – May 13, 2025 – TheNewswire - Femto Technologies Inc. (Nasdaq: FMTO), a pioneering Femtech company formerly known as BYND Cannasoft Enterprises Inc., announced today that the U.S. Patent and Trademark Office (USPTO) has granted it a Notice of Allowance for its female treatment device – sensera design. This milestone reinforces Femto's commitment to redefining wellness solutions through AI-driven advancements.» Mehr auf thenewswire.com